Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KIF22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CDC34 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCML4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MCM7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC101926916 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SSH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR83OS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MXD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR2J2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACOT7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORA70 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM65A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC137 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPIL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LTBP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on